Moberg Pharma Shares Owned By Insiders vs. Operating Margin

MOB Stock  SEK 15.48  0.03  0.19%   
Based on the key profitability measurements obtained from Moberg Pharma's financial statements, Moberg Pharma AB may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Moberg Pharma's ability to earn profits and add value for shareholders.
For Moberg Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Moberg Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Moberg Pharma AB utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Moberg Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Moberg Pharma AB over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
Please note, there is a significant difference between Moberg Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Moberg Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moberg Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Moberg Pharma AB Operating Margin vs. Shares Owned By Insiders Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Moberg Pharma's current stock value. Our valuation model uses many indicators to compare Moberg Pharma value to that of its competitors to determine the firm's financial worth.
Moberg Pharma AB is considered to be number one stock in shares owned by insiders category among its peers. It also is considered to be number one stock in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Moberg Pharma's earnings, one of the primary drivers of an investment's value.

Moberg Operating Margin vs. Shares Owned By Insiders

Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Moberg Pharma

Insiders Shares

 = 

Executives Shares

+

Employees

 = 
18.07 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Moberg Pharma

Operating Margin

 = 

Operating Income

Revenue

X

100

 = 
(97.71) %
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.

Moberg Operating Margin Comparison

Moberg Pharma is currently under evaluation in operating margin category among its peers.

Moberg Pharma Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Moberg Pharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Moberg Pharma will eventually generate negative long term returns. The profitability progress is the general direction of Moberg Pharma's change in net profit over the period of time. It can combine multiple indicators of Moberg Pharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Moberg Pharma AB , a pharmaceutical company, develops and commercializes medical products for pain and skin conditions in Europe, the United States, and internationally. Moberg Pharma AB was incorporated in 2006 and is headquartered in Bromma, Sweden. Moberg Pharma operates under Drug ManufacturersSpecialty Generic classification in Sweden and is traded on Stockholm Stock Exchange. It employs 11 people.

Moberg Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Moberg Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Moberg Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Moberg Pharma's important profitability drivers and their relationship over time.

Use Moberg Pharma in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Moberg Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moberg Pharma will appreciate offsetting losses from the drop in the long position's value.

Moberg Pharma Pair Trading

Moberg Pharma AB Pair Trading Analysis

The ability to find closely correlated positions to Moberg Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Moberg Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Moberg Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Moberg Pharma AB to buy it.
The correlation of Moberg Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Moberg Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Moberg Pharma AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Moberg Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Moberg Pharma position

In addition to having Moberg Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Education Thematic Idea Now

Education
Education Theme
Companies involved in apprenticeship, education, tutoring, schooling, online universities, and other learning services. The Education theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Education Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Moberg Stock Analysis

When running Moberg Pharma's price analysis, check to measure Moberg Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moberg Pharma is operating at the current time. Most of Moberg Pharma's value examination focuses on studying past and present price action to predict the probability of Moberg Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moberg Pharma's price. Additionally, you may evaluate how the addition of Moberg Pharma to your portfolios can decrease your overall portfolio volatility.